In silico validation of a new classifier, PCSCG(ier), for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets

Detalles Bibliográficos
Autores principales: Zhang, Meng, Bian, Zichen, Chen, Jia, Chen, Lei, Zhou, Jun, Niu, Qingsong, Hao, Zongyao, Meng, Jialin, Liang, Chaozhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841121/
https://www.ncbi.nlm.nih.gov/pubmed/36642929
http://dx.doi.org/10.1002/ctm2.1105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841121/
https://www.ncbi.nlm.nih.gov/pubmed/36642929
http://dx.doi.org/10.1002/ctm2.1105

Ejemplares similares